ClinicalTrials.Veeva

Menu
R

Retina Consultants of Charleston | Retina Research of Beaufort

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KSI-301
Aflibercept
Avacincaptad pegol
Zimura

Parent organization

This site is a part of Retina Consultants of Charleston

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

The purpose of this study is to assess long-term safety of avacincaptad pegol intravitreal administration for patients with geographic atrophy (GA) w...

Active, not recruiting
Age-Related Macular Degeneration
Geographic Atrophy
Drug: avacincaptad pegol

RGX-314 is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD). Wet AM...

Enrolling
Wet Age-related Macular Degeneration
WetAMD
Genetic: RGX-314 Dose 2
Biological: Aflibercept (EYLEA®)

Trial sponsors

Kodiak Sciences logo
AbbVie logo
Astellas logo
I

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems